Apply for the CRIS Cancer-Princess Margaret drug development fellowship CRIS contra el cáncer Princess Margaret Cancer Centre - great opportunity for those with interests in phase I trials and translational research criscancer.org/es/cris-prince…

🔴 Llega la entrega de la beca Princess Margaret Cancer Centre drug development fellowship program con el objetivo de formar investigadores de España, Francia y el Reino Unido en el Princess Margaret Cancer Centre Research de Toronto en terapia experimental e investigación traslacional. 

#DíaCienciaCRIS24

Can a blood sample be used to predict patient outcomes to #cancer #immunotherapy drug pembrolizumab? Researchers Enrique Sanz-Garcia, Eric Stutheit-Zhao and Lillian Siu from Princess Margaret Cancer Centre Research investigate this in their new study. Read more > uhnresearch.ca/news/assessing…; doi.org/10.1158/2159-8…

Last day to submit your abstracts to #ASCOBT24 !!

Lots of research awards for the top40 ranked abstracts and also Merit awards for trainees!

Junior faculty and trainees opportunities are also being lined up 😊

ASCO ASCOPres Lillian Siu

Celebration of 25 yr anniversary of women in cancer research - room full with women and men @aacr #aacr24 AACR_CEO

I was delighted to join AACR President Patricia M. LoRusso Phil Greenberg, @AACR President-Elect Pat LoRusso, and President-Elect Designate Lillian Siu at the #AACR24 Board of Directors meeting. We thank our officers and board members for all they do to advance the AACR's mission.

Full house in pre @aacr inaugural AACR Oncology Industry Partnering Event - exciting pipelines and drug development paths 🔥🔥🔥

The AACR Annual Meeting 2024 Program Guide App is available for download. Learn more:
bit.ly/3TKYbrs
#AACR24

It was a great pleasure interviewing Pasi Jänne on OncoDaily, a world-known translational medical oncologist focused on improving the lives and outcomes of patients with lung cancer, Senior Vice President for Translational Medicine at Dana-Farber.

11 days to submit your abstracts for #ASCOBT24
Deadline 9 April 2024 US ET!

We are all inclusive for #CancerResearch
#CancerCare
#TranslationalResearch
#ClinicalTrials
#Innovation

Check out the amazing line-up of speakers! Lillian Siu ASCO
conferences.asco.org/breakthrough/p…

#ASCOBT24 @asco Aug 8-10, 2024 in Yokohama, Japan. Chaired by the dynamic Melvin LK CHUA. Exciting agenda with relevant topics across disciplines. Submit abstract by 11:59 PM ET April 9.

Learn more ➡️ brnw.ch/21wI0V9

In the city of lights, we’re illuminating breakthrough innovations and research that are improving global cancer care today—and you need to be there to see it. Join us at ASCO Breakthrough in Yokohama, Japan.

🔴📣 CONVOCATORIA BECA Princess Margaret Cancer Centre - CRIS

🔸Dirigida a médicos investigadores se formen en Desarrollo de Medicamentos en el Princess Margaret Cancer Centre

🔸 Con algunas de los mayores especialistas como la Dra. Anna Spreafico y Lillian Siu

Más info👉 ow.ly/CCKC50QU5fj

.Margaret Foti, PhD, MD (hc) Margaret Foti invites the cancer research community to attend #AACR24 next month in San Diego. Read more in AACR Annual Meeting News: bit.ly/49P5569

40 Year Anniversary of cloning of the T cell receptor - the forerunner of all the magic happening in B cell malignancy therapy today - Princess Margaret Cancer Centre University Health Network scientist Tak Mak now working on TCR therapy for #myeloma with support of Roger and Paula Riney foundation and The Princess Margaret Cancer Foundation

Alumni Award winner Prof. Christophe Le Tourneau received his award and gave an excellent talk on precision medicine in oncology at a special Princess Margaret Cancer Centre Grand Rounds this morning.

Do submit your abstracts to #ASCOBT24

Deadline in a month 9 Apr 2024!
asco.confex.com/asco/bts2024/c…

Listen to Dr. Yan Leyfman on Why You Should Submit to #ASCOBT24 ASCO Lillian Siu Hidehito HORINOUCHI Naoto T Ueno, MD, PhD
youtu.be/PEQjfaCN59Y?si… via YouTube

An amazing #ESMOTAT24 congress and amazing Scientific Chairs! Thank you!
Lillian Siu Elena Garralda Anastasios Stathis ESMO - Eur. Oncology

#ESMOTAT2023 starting. Amazing agenda and very excited to see so many attendees from all over the world in this important drug development meeting👏👏👏

#ESMOTAT24
Ready to join ✈️ ESMO - Eur. Oncology
🪑Lillian Siu Elena Garralda
🕔 17:15 Pass by poster display
93P: Alice Rossi will explain 360 RESISTANCE project of #TT in #ECT
99P: Giulia Pretelli molecular analysis+treatment of patients with 🧠 Mets #ECT
#CancerResearch Vall d’Hebron Institute of Oncology (VHIO)
👇🏼👇🏼